New Study Demonstrates Clinical Validity of Lung Cancer Test EarlyCDT-Lung
Oncimmune (USA) LLC, provider of EarlyCDT-Lung, announces the publication of a study that demonstrates the clinical validity of the test.
Read MorePosted by Clinical Lab Products | Aug 9, 2010 | Cancer, Miscellaneous |
Oncimmune (USA) LLC, provider of EarlyCDT-Lung, announces the publication of a study that demonstrates the clinical validity of the test.
Read MorePosted by Clinical Lab Products | Jul 12, 2010 | Cancer, Miscellaneous |
Researchers at the University of Cincinnati (UC) and Cincinnati Children’s Hospital Medical Center have found that a certain blood test can successfully identify lymphangioleiomyomatosis (LAM) in some patients, eliminating the need for surgical lung biopsy to make a diagnosis.
Read MorePosted by Clinical Lab Products | Jun 14, 2010 | Molecular Diagnostics |
Veracyte Inc announced the successful completion of its Series B round, a key milestone toward the companys first product launch later this year. Veracyte seeks to develop and commercialize molecular cytology solutions to improve the early and accurate diagnosis of cancer.
Read MorePosted by Clinical Lab Products | Jun 14, 2010 | Cancer, Miscellaneous |
Radient Pharmaceuticals Corp (RPC) has launched a new interactive Web site for its USFDA-approved Onko-Sure in vitro diagnostic (IVD) cancer test.
Read MorePosted by Clinical Lab Products | Jun 5, 2010 | Cancer, Miscellaneous |
This month’s cover story on mass spectrometry for the clinical lab is the first CLP has published on this topic, but I don’t believe it will be our last. According to sources at the FDA and the National Cancer Institute’s proteomics prog
Read More